UnknownNCT05284305
Desmoid Tumor and Pregnancy: Effect of Pregnancy on Disease Control and Effect of Diagnosis on Pregnancy History.
Studying Desmoid tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Principal Investigator
- Marco Fiore, MDFondazione IRCSS Istituto Nazionale Tumori
- Intervention
- Pregnancy(other)
- Enrollment
- 400 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2022 – 2023
Study locations (7)
- Brigham and Women Hospital / Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Mount Sinai Hospital/Toronto University, Toronto, Canada
- Institut Curie, Paris, France
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Desmoid Foundation Italy, Milan, Italy
- Istituto Oncologico Veneto IRCSS, Padua, Italy
- University of Padova, Padua, Italy
Collaborators
University of Padova · Institut Curie · Dana-Farber/Brigham and Women's Cancer Center · Mount Sinai Hospital, Canada · Desmoid Foundation Italia · Istituto Oncologico Veneto IRCCS
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05284305 on ClinicalTrials.govOther trials for Desmoid tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07541430A Study in Adults With Desmoid TumorsElpiscience (Suzhou) Biopharma, Ltd.
- RECRUITINGPHASE4NCT07176689Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT07170644A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc.
- RECRUITINGNCT06945887Treatment of Desmoid Fibromatosis With Arterial EmbolizationIstituto Ortopedico Rizzoli
- RECRUITINGNCT07496242Immunological Phenotype of Desmoid-fibromatosis-affected Patients.Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- RECRUITINGPHASE2NCT05879146Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyM.D. Anderson Cancer Center
- RECRUITINGNCT06660121Electrochemotherapy for Desmoid TumorsIstituto Ortopedico Rizzoli
- RECRUITINGNANCT06081400Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful WaitingUniversity Hospital, Strasbourg, France